These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 9658403)

  • 21. Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin.
    Ning YM; Sánchez ER
    J Biol Chem; 1993 Mar; 268(9):6073-6. PubMed ID: 7681058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin.
    Silverstein AM; Galigniana MD; Chen MS; Owens-Grillo JK; Chinkers M; Pratt WB
    J Biol Chem; 1997 Jun; 272(26):16224-30. PubMed ID: 9195923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid receptor interactions with heat shock protein and immunophilin chaperones.
    Pratt WB; Toft DO
    Endocr Rev; 1997 Jun; 18(3):306-60. PubMed ID: 9183567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct interaction of the Krüppel-like family (KLF) member, BTEB1, and PR mediates progesterone-responsive gene expression in endometrial epithelial cells.
    Zhang D; Zhang XL; Michel FJ; Blum JL; Simmen FA; Simmen RC
    Endocrinology; 2002 Jan; 143(1):62-73. PubMed ID: 11751593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
    Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex.
    Dittmar KD; Banach M; Galigniana MD; Pratt WB
    J Biol Chem; 1998 Mar; 273(13):7358-66. PubMed ID: 9516432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
    Deroo BJ; Archer TK
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51.
    Reynolds PD; Ruan Y; Smith DF; Scammell JG
    J Clin Endocrinol Metab; 1999 Feb; 84(2):663-9. PubMed ID: 10022435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stabilization in vitro of the untransformed glucocorticoid receptor complex of S49 lymphocytes by the immunophilin ligand FK506.
    Ning YM; Sanchez ER
    J Steroid Biochem Mol Biol; 1995 Feb; 52(2):187-94. PubMed ID: 7532989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
    Selkirk JK; Merrick BA; Stackhouse BL; He C
    Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells--a possible interaction with psychotropic drugs.
    Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Leśkiewicz M; Tetich M; Otczyk M; Kubera M; Lasoń W
    Eur Neuropsychopharmacol; 2007 Jan; 17(1):37-45. PubMed ID: 16581232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FK506 binding to the 56-kilodalton immunophilin (Hsp56) in the glucocorticoid receptor heterocomplex has no effect on receptor folding or function.
    Hutchison KA; Scherrer LC; Czar MJ; Ning Y; Sanchez ER; Leach KL; Deibel MR; Pratt WB
    Biochemistry; 1993 Apr; 32(15):3953-7. PubMed ID: 7682438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.
    Narayanan R; Edwards DP; Weigel NL
    Mol Cell Biol; 2005 Apr; 25(8):2885-98. PubMed ID: 15798179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
    Zhang X; Jeyakumar M; Bagchi MK
    J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
    Read LD; Snider CE; Miller JS; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1988 Mar; 2(3):263-71. PubMed ID: 3398853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor.
    Nair SC; Rimerman RA; Toran EJ; Chen S; Prapapanich V; Butts RN; Smith DF
    Mol Cell Biol; 1997 Feb; 17(2):594-603. PubMed ID: 9001212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.